Multiple Sclerosis Trial, Recruiting NCT06826638 Sponsor: Fondazione Don Carlo Gnocchi ETS Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06826638
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 60 years of age
  • People who have been diagnosed with Multiple Sclerosis (MS) using established diagnostic guidelines, whose condition has been stable (not significantly worsening) over the last 3 months, and whose MS-related disability falls within a specific moderate range as measured by a standard scoring tool called the EDSS (confirm with trial site for exact score details)
  • Healthy volunteers who are right-handed
  • People who are able to read and sign a written consent form agreeing to take part

Who may not be able to join:

  • People who are unable to understand the purpose of the study or follow the instructions involved in testing
  • People who have been diagnosed with major depression (as defined by standard psychiatric guidelines known as DSM-5)
  • People who have serious joint or bone problems that affect their balance or ability to walk, based on a doctor's assessment
  • People who have cardiovascular (heart or blood vessel) disease
  • People who have serious vision problems that would prevent them from completing the study tasks
  • People who have epilepsy
  • People who are currently taking antipsychotic medications (neuroleptics) or anti-seizure medications (antiepileptics)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondazione Don Carlo Gnocchi ETS
Registry
ClinicalTrials.gov
Start date
1 September 2023
Est. completion
31 July 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Head and trunk movements quantified with Inertial Measurement Units (IMU); Cortical activation with Functional Infrared Spettroscopy (fNIRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov